Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Child and Adolescent Psychopharmacology|October 19, 2021
Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and SuicidalityDavid S Mathai, Alexis G McCathern, Andrew G Guzick, et al.
Pharmacological Research|November 29, 2023
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment modelsDavid B Yaden, Andrea P Berghella, Peter S Hendricks, et al.
The International Journal of Neuropsychopharmacology|May 14, 2021
Psychedelics and Consciousness: Distinctions, Demarcations, and OpportunitiesDavid B Yaden, Matthew W Johnson, Roland R Griffiths, et al.
Journal of Psychoactive Drugs|February 8, 2025
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin UseDavid S Mathai, Daniel E Roberts, Sandeep M Nayak, et al.
The American Journal of Drug and Alcohol Abuse|June 29, 2022
Kratom use as more than a "self-treatment"Kirsten E Smith, Kelly E Dunn, Jeffrey M Rogers, et al.
Frontiers in Pharmacology|May 22, 2023
Examining the paradoxical effects of kratom: a narrative inquiryKirsten E Smith, Jeffrey D Feldman, Kelly E Dunn, et al.
Scientific Reports|February 25, 2026
Pilot study of psilocybin in patients with post-treatment lyme diseaseAlbert Garcia-Romeu, Gideon P Naudé, Alison W Rebman, et al.
Psychiatry Research|February 26, 2026
Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy onesSean P Goldy, Nathan D Sepeda, Samantha N Hilbert, et al.
Journal of Psychopharmacology (Oxford, England)|February 1, 2025
Impact of psychedelics on craving in addiction: A systematic reviewSophie-Athéna Chapron, Guilhem Bonazzi, Laura Di Lodovico, et al.
Substance Abuse|June 3, 2022
Need for clarity and context in case reports on kratom use, assessment, and interventionKirsten E Smith, Kelly E Dunn, David H Epstein, et al.
Pageof 7